Halemah Alsaeed

SEP 7, 2026 · JOURNAL ARTICLE

Myosteatosis in type 1 diabetes: immunometabolic mechanisms, biomarkers, and therapeutic targets

Frontiers in Endocrinology

This is a narrative review synthesizing evidence from multiple disease models to generate a mechanistic framework for myosteatosis in T1D; the authors explicitly state direct mechanistic data from T1D skeletal muscle are scarce and the framework is deliberately hypothesis-generating, assembled substantially by inference from T2D, obesity, and ageing models.